Single-Cell & Spatial for Drug Discovery
International Conference: 10-11 June 2026, Berlin, Germany
Powering Discovery through Multi-Modal Profiling
The conference provides a platform for researchers, technologists, and industry experts to explore how single-cell and spatial technologies are transforming drug discovery by providing deeper insights into disease mechanisms, cellular heterogeneity, functional biology, and multi-modal data-driven discovery.
Keywords: single-cell, spatial biology, functional genomics, crispr screening, disease mechanisms, cellular heterogeneity, biomarker discovery, target identification, AI-powered discovery, multi-modal data, preclinical development, drug discovery
Interdisciplinary meetup: who should attend
- Researchers in preclinical drug discovery and functional genomics
- Translational scientists and pharmacologists focused on targets and biomarkers.
- Computational biologists and data scientists using single-cell, spatial, and multi-modal data./li>
- Biotech and pharma professionals in preclinical and early therapeutic development
- Technology developers and platform providers in single-cell, spatial, CRISPR, and AI
Topics
including but not limited to:
Functional Genomics
Identify and validate potential drug targets by single-cell CRISPR screening, testing how gene changes affect cell behavior.
Disease Pathology
Profile heterogeneity and rare cell types using single-cell and spatial analysis to reveal key populations involved in disease progression and drug response.
Biomarker Discovery & Validation
Detect and confirm markers with single-cell and spatial profiling that predict disease response, supporting more efficient drug development and precision therapies.
AI-Powered Discovery
Combine single-cell and spatial multimodal data with AI to discover new drug targets and biomarkers.
Connecting Industry and Academia
This conference goes beyond traditional discussions of drug discovery. It serves as a meeting point and communication hub for academic and industry participants to showcase innovative single-cell and spatial approaches, emerging multi-modal platforms, and cutting-edge technologies advancing preclinical drug discovery and development.
By connecting participants across the value chain, the Conference fosters interdisciplinary exchange that drives technology transfer, commercialization, and real-world application of innovations.
